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Summary 
It has previously been shown in T cells that stimulation of protein kinase C  (PKC) or the T 
cell antigen receptor (TCR) induces the rapid accumulation of the active guanosine triphosphate- 
bound form of p21 ~a~. These stimuli also induce the activation of extraceUular signal-regulated 
kinase 2 (ERK2), a serine/threonine  kinase that is rapidly activated via a kinase cascade  in response 
to  a variety of growth factors in  many cell types.  In this  study,  we show that  p21  r~ is  a 
component of the TCR signaling pathway that controls ERK2 activation. In the human Jurkat 
T cell line, transient expression of constitutively active p21 ~ induces ERK2 activation, measured 
as an increase in the ability of an ERK2-tag reporter protein to phosphorylate myelin basic protein. 
Thus, constitutively active p21  r~ bypasses the requirement for PKC activation or TCR triggering 
to induce ERK2 activation.  In addition,  activation of PKC or the TCR produces signals that 
cooperate  with  activated  p21 r'~  to  stimulate  ERK2.  Conversely,  expression  of a  dominant 
negative mutant of ras, Ha-ras N17, blocks ERK2 activation after TCR stimulation,  indicating 
that endogenous p21 r~ function is necessary for the TCR-stimulated ERK2 activation.  Taken 
together, these results demonstrate that the activation of p21 r.~ is both necessary and sufficient 
to induce ERK2 activation in T  cells. 
T 
he TCR is the crucial receptor that controls the activa- 
tion of T lymphocytes. One immediate consequence of 
triggering the TCR is the activation of cytosolic src family 
protein tyrosine kinases (PTKs)  1 and the resulting induction 
of phospholipase C3,1-mediated hydrolysis of inositol phos- 
pholipids to generate diacylglycerol  and inositol polyphosphates 
which induce protein kinase C (PKC) activation and elevate 
intraceUular  calcium, respectively  (1). Recently, a second PTK- 
controlled signaling pathway originating from the TCR has 
been identified,  one that couples the TCR to the guanine 
nucleotide binding proteins p21 ras (2, 3). The p21 r~ proteins 
cycle  between an "inactive" GDP-bound and an "active" GTP- 
bound form. In quiescent T cells, p21 ras exists in a complex 
with GDP but, after triggering of the TCR, there is a rapid 
and stable accumulation of p21  r'~ GTP complexes. In T lym- 
phocytes p21 r'~ is stimulated  not only in response to TCR 
triggering but also after the activation of PKC with phorbol 
esters and diacylglycerols (2). However, the role of PKC in 
1  Abbreviations  used in this  ~per: ERK, extracellular signal-regulated kinase; 
MAP, mitogen-activated  protein; MBP, myelin basic protein; PKC, protein 
kinase C. 
p21 ras regulation is  poorly understood and,  although the 
TCR activates PKC, the TCR does not regulate ras via PKC. 
Instead,  a parallel PKC-independent,  but PTK-dependent 
pathway seems to be responsible for TCR-stimulated p21 r~s 
activation  (3). 
The importance of p21 r~s in T cells has been examined by 
expressing transfected genes encoding either constitutively 
active or dominant inhibitory mutants of p21 r*s (4, 5). An 
important function of the TCR is to control the expression 
and activation of transcription factors essential for the induc- 
tion of the gene encoding the T cell growth factor IL-2 (6). 
Expression of a dominant inhibitory mutant of p21 ra' pre- 
vents both TCR and PKC induction of IL-2 (4). Further- 
more, expression of a constitutively active p21 ~a' initiates a 
signaling pathway that synergizes with signals generated by 
increasing cytosolic  calcium to induce the IL-2 gene (4). These 
data indicate  that cellular p21 ras has a vital  role in TCR- 
stimulated IL-2 induction. 
In fibroblasts and the pheocytochromocytoma  PC12 cell 
line, the transmission of signals from p21  r~ to the nucleus 
is proposed to involve  the regulation of the activity of  mitogen- 
activated protein (MAP) kinases or extracellular signal-regu- 
lated kinases (ERK) (7-10).  T lymphocytes express at least 
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tivity of ERK2 is stimulated in response to TCR and PKC 
activation (11, 12). Previous  studies have suggested that the 
TCR either regulates the ERKs via PKC (11) or via an alter- 
native PTK-dependent pathway involving the kinase p561r 
(13). However, any link between TCR-regulated p21 =s and 
the activation of MAP kinases  has not yet been explored. 
The kinetics of TCR stimulation of p21 r~s and the ERKs 
correlate (2,  12), but such a correlation does not prove that 
p21 =~ couples the TCR to ERKs as active p21TM does not 
always lead to ERK2 activation. For instance,  it has been 
reported that the IL-2 receptor, which is as potent as the TCR 
in regulating the guanine nucleotide binding cycle of p21 r~+ 
(14), can activate ERK2 when expressed in myeloid cells (15), 
but IL-2 is not a potent activator of ERKs in T lymphocytes 
(16,  17). Furthermore,  although p21 r~s activates  ERKs in 
several cultured cell lines (7-10),  in Rat-la fibroblasts,  the 
expression  of constitutively active  p21 ~  fails  to  activate 
ERKs (18). Also, in fibroblasts,  phorbol ester-induced ERK 
activation is insensitive to expression  of a dominant inhibi- 
tory ras mutant, and in these cells, PKC may function down- 
stream of p21 =~ (10, 19). 
The purpose of the present study was to attempt to posi- 
tion  p21TM on  the  pathway via  which  the  TCK induces 
ERK2 activation. Data obtained from transfection studies 
show that expression  of a constitutively active p21 v-Ha-ras 
in T  cells is a sufficient  signal to stimulate the activity of 
the MAP kinase ERK2. Moreover, inhibition of endogenous 
p21 ~+ function by the dominant inhibitory mutant N17 ras 
suppresses TCR induction of  ERK2 activity. These data dem- 
onstrate that p21 ~  proteins are pivotal for the regulation of 
ERK2 in T cells and suggest that one mechanism whereby 
p21 =~ regulates T  cell activation is via the activation of the 
ERK cascade. 
Material and Methods 
Plasmids and Antibodies.  A tagged ER.K2  reporter construct was 
generated as described (19) using a COOH-terminal epitope tag 
from c-rayc which is recognized by the mAb antibody 9E10. The 
ERK 2-tag encoding DNA was subcloned into the mammalian 
expression vector pEF-Bos (20). The pEF-Bos expression vector was 
also used to direct expression of a constitutively active p21", p21 
v-Ha-ras. The expression  vector for a dominant inhibitory ras con- 
struct (N17 ms) has been described previously (21, 22): a 4.8-kb 
genomic fragment of c-Ha-ras which bears a mutant at codon 17 
(Set -* Ash) expressed under the control of the RSV promoter. 
The RSV expression vector pB59W was used as an empty vector 
control as indicated. The antibodies UCHT1 and 9E10, reactive 
with the e chain of the human TCR-CD3 antigen complex and 
the c-myr  epitope tag, respectively,  were purified from hybridoma 
supernatants by affinity  chromatography  with protein A-Sepharose. 
Cells and Transfections.  TheJurkat T leukemia cells were main- 
tained in RPM11640 supplemented  with 10% heat inactivated  FCS. 
Growth was at 37~  in a humidified 5% CO2/95% air incubator 
Cells were transfected via electroporation (Gene Pulser; Bio-Rad, 
Hemel Hempstead, UK), according to the manufacturer's instruc- 
tions. Briefly, cells were incubated with the indicated concentra- 
tion of plasmid DNA and then pulsed (1-1.5  x  107 in 0.5 ml 
medium) at 960 gF and 310V. Transfected  cultures were maintained 
in culture for 24 h and afterwards were harvested for subsequent 
procedures. 
Western Blotting.  Acetone-precipitated  protein from cell lysates 
corresponding to  10  + cells was  resolved in  12.5% SDS-PAGE 
minigels. Blots were probed as previously  described  (19) with 9E10 
antibody to visualize the ERK2-tag protein. To detect transfected 
and endogenous ras proteins, Wester blots were probed with a anti- 
pan ras antibody. To detect immunocomplexes, the Western blots 
were probed with horseradish peroxidase-coupled rabbit anti- 
mouse followed  by enhanced  chemiluminescence  (Amersham Intl., 
Bucks, UK). 
p21" Activation.  p21 ~ proteins were immunoprecipitated  with 
antibody Y13-259 from cells in which guanine nucleotides were 
labded biosynthetically  with [32p] orthophosphate as described (2). 
Labded guanine nudeotides bound to ras were eluted, separated 
by thin-layer  chromatography, and then quantitated by direct scan- 
ning for B radiation using a B scanner (Ambis, Inc., San Diego, 
CA). Results are expressed as proportion of p21" bound to GTP. 
Analysis of ERK2-tag Kinase Activity.  Jurkat cells were trans- 
fected with the indicated concentration of pEF-BOS ERK2-tag. 
After 24 h 1.5-1  x  106 cells per assay  point were activated as in- 
dicated at 37~  in I ml of  RPMI 1640. Thereafter,  immunoprecipi- 
tates of  ER.K2-tag  were prepared using the 9E10 mAb. Briefly,  cells 
were lysed in 0.5 ml lysis buffer (50 mM Hepes [pH, 7.4], 150 
mM NaCI, 20 mM NaF, 20 mM iodacetamide, 1 mM PMSF, and 
100/tM NaVO4). After 20 min of preclearing with insoluble pro- 
tein A-Sepharose suspension, lysates were incubated for 20 min 
with 2 gg of 9E10 antibody, then for 1 h with 20/~1 of a 50% 
suspension of  protein G-Sepharose  beads (Sigma Chemical Co., St. 
Louis, MO). Immunoprecipitates were washed three times with 
lysis buffer and once with kinase assay buffer (30 mM Tris [pH, 
8], 20 mM MgClz, and 2 mM MnC12). In vitro kinase assays  were 
carried out for 30 min at room temperature in 20 gl of kinase assay 
buffer supplemented with 10 gM ATP, 5 gCi 3~-[32P]ATP and 10 
gg myelin basic protein (MBP) as a substrate. The kinase reaction 
was stopped with 20 gl of2x SDS sample  buffer and samples were 
run in 15% SDS-PAGE minigels. Quantitation of 3zp incorporated 
into the MBP protein band was done by B radiation scanning of 
dried gels using a scanner (Ambis, Inc.). All MBP kinase activity 
in ERK2-tag immunoprecipitates was normalized to the relative 
amount of ERK2-tag protein expressed in different cell popula- 
tions as assessed by Western blotting analysis. 
Results 
TCR  Triggering  and PKC  Stimulation  Activate  p21 ras  in 
Jurkat  Cells.  To  confirm that p21 r's  is  regulated via  the 
TCR and PKC in the Jurkat ceUs used in the present study, 
p21r's-GTP  loading experiments were performed. Endoge- 
nous guanine nucleotides were metabolically labeled  with 
[3Zp]orthophosphate  and p21 =+ protein was immunoprecip- 
itated from Jurkat ceils exposed either to the antibody UCHT1 
that triggers the TCR or to the phorbol ester  PDBu that 
directly activates  PKC. The proportion of p21  TM  bound to 
GTP (the ratio between GTP and GTP plus GDP labeled 
nucleotides on p2P  s) was evaluated by ~ emission scanning 
of TLC-resolved guanine nucleotides eluted from immuno- 
precipitated ras proteins. Fig. 1 shows that PKC stimulation 
with PDBu increased  the level of GTP bound to ras from 
6% in unstimulated Jurkat to 34% (five- to sixfold). TCR 
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Figure  1.  Effect of PDBu and TCK agonist UCHT1 on the activation 
state of p21 '~ in Jurkat cells. Cells labeled with [32p]orthophosphate  as 
indicated  in Materials and Methods were either unstimulated  (control)  or 
stimulated for 10 min with 100 ng/ml PDBu or 10 #g/ml UCHT1. Im- 
munoprecipitation  of p21'~ was with mAb Y13-259 and nucleotides were 
separated by TIC. The figure shows the quantitation of guanine nucleo- 
tides  on p21TM by direct scanning  of/8 radiation.  Data are expressed as 
percentage of GTP bound to ras with respect to the total amount of gua- 
nine nucleotide on ras and are average (mean  _+  SD) of the data obtained 
in four experiments. 
triggering with UCHT1 resulted in a threefold increase in 
the proportion  of GTP-bound ras  (from 6  to  19%). 
Expression  and  Regulation  of ERK2-tag  in Jurkat  Cells. 
Previous studies (4, 5) have established that transient  trans- 
fection protocols provide a powerful system for the analysis 
of p21TM function in T  cells. Since the transfection efficiency 
in Jurkat cells is about 10-30%, attempts to examine the effects 
of transient  expression of p21TM mutants on ERK2 activity 
require the use of a reporter construct. Accordingly, a MAP 
kinase reporter construct (ERK2-tag) was generated to ex- 
press ERK2 epitope tagged with a c-myc  polypeptide that 
is recognized by the mAb 9El0.  The 9E10 epitope allows 
both Western blot quantitation and immunoprecipitation of 
ERK2-tag in transfected cells so that the expression and acti- 
vation of ERK2 in cells coexpressing mutant ras can be as- 
sessed (19). 
In  initial  experiments,  the  expression  and  activation  of 
ERK2-tag in response to TCK or PKC stimulation was ex- 
amined.  Fig. 2 a shows a Western blot developed with the 
9E10 antibody of cell lysates isolated from Jurkat cells 24 h 
after the cells were transfected either with a control empty 
expression vector or the ERK2-tag expression vector. Cells 
transfected with the ERK2-tag construct expressed a 9E10- 
reactive 42-kD band corresponding  to the predicted mole- 
cule weight of the ERK2-tag protein.  The basal kinase ac- 
tivity of the transfected ER.K2-tag was assessed by kinase assays 
on the 9E10 immunoprecipitates using MBP as a substrate. 
The basal kinase activity of the ERK2-tag isolated from un- 
stimulated cells was weak (Fig. 2 b). However, if the trans- 
fected Jurkat cells were stimulated with PDBu or UCHT1 
for 5 min there was a marked increase in the MBP kinase 
activity in the ERK2-tag immunoprecipitates (Fig. 2 b). The 
data in Fig. 2 c summarizes data from five experiments.  A 
5-min stimulation of  Jurkat cells with PDBu induced a 15-20- 
fold increase in ERK2-tag kinase activity; whereas the stimula- 
tory effect of the TCK agonist antibody UCHT1 was a 10-15- 
fold increase.  No MBP kinase activity was ever detected in 
9E10 immunoprecipitates  isolated from either quiescent or 
activated nontransfected Jurkat  cells  (Fig.  2  b). 
Kinetic analysis of ERK2 kinase activation  (Fig. 2 d) showed 
that  maximal  stimulation  occurs  within  10  min  of both 
UCHT1 and PDBu stimulation.  ERK2-tag stimulation in 
response to UCHT1 decreased after 30 min, although a two- 
fold increase in activity was still detectable at 60 rain.  The 
PDBu response also declined after 30 min but was sustained 
at 50%  of the maximal  stimulation  at 60 min.  Increasing 
intracellular  calcium in T  cells does not activate p21  r" (2). 
The data in Fig. 2 c show that ERK2-tag kinase activity in 
Jurkat cells stimulated with the calcium ionophore Ionomycin 
was similar to the basal kinase activity present  in nonacti- 
vated cells. Thus the ERK2-tag kinase activity is stimulated 
after TCR or PKC stimulation but not in response to in- 
creases  in intracellular  calcium.  The kinetics of ERK2-tag 
activation as well as the relative magnitude of TCR versus 
PKC stimulation are exactly consistent with the regulation 
of endogenous ERK2 activity described in previous studies 
(11,  12). 
p21 r~ Activates ERK2.  To determine whether p21 ~  is in- 
volved in the signaling pathways that regulate ERK2, a muta- 
tionally activated ras protein (v-Ha ras) was coexpressed in 
Jurkat cells with ERK2-tag.  v-Ha-ras is mutated at codon 
12 (G --* R) and 59 (A -* T). These mutations decrease the 
intrinsic GTPase activity of p21 r~ and render the protein in- 
sensitive to GTPase activating proteins so that the active GTP- 
bound form of p21 ~" accumulates and has a positive domi- 
nant effect (23). Fig. 3 a shows a Western blot of cell lysates 
from Jurkat cells cotransfected with either ERK2-tag and a 
control empty vector or EKK2-tag plus v-Ha-ras. The Western 
blot was probed initially with 9E10 antibody to check ex- 
pression of ERK2-tag (Fig. 3 a, left) and subsequently with 
a anti-pan  ras antibody in order to assess the expression of 
the endogenous and transfected ras proteins (Fig. 3 a, right). 
These Western blots show that the level of ERK2-tag in ras 
transfected cells was comparable to the usual level of ERK2- 
tag in non ras transfected cells.  The anti-pan  ras  antibody 
used in the present  study cannot distinguish  normal p21 ~' 
from the mutated v-Ha-ras but the expression of v-Ha-ras 
in transfected cells can be judged by the overexpression of 
ras in the v-Ha-ras transfected cells compared to either un- 
transfected or empty vector control transfectants  (Fig.  3 a, 
rieht). 
To examine the consequences of p21 v-Ha-ras expression 
on ERK2 activity, MBP kinase assays were carried out on 
EKK2-tag immunoprecipitates isolated from v-Ha-ras or con- 
trol transfected cells. Fig. 3 b shows the SDS-PAGE analysis 
1201  Izquierdo et al. Figure 2.  Transient expression and regulation of ERK2-tag in Jurkat cells. (a) Jurkat cells were transfected as indicated in Materials and Methods 
with either  30 #g of the pEF-ERK2-tag  vector (lane I) or the pEF empty vector (lane 2). After 24 h of transfection,  Western blot of the lysates 
was developed with 9E10 antibody. Lane 3 corresponds to a lysate from untransfected cells. (b) Lysates from untramfected cells (-) or cells transfected 
with 30/~g of pEF-ERK2-tag  (ERK2) and either unstimulated (C) or stimulated for 10 min with 100 ng/ml PDBu (P) or 10/~g/ml TCR agonist 
(7) were immunoprecipitated  with the 9E10 antibody. Kinase assays with MBP as a substrate were set up on the immunoprecipitates  (IP) and MBP 
phnsphorylation was visualized by autoradiography after 15% SDS-PAGE of the products of the kinase assay. (Arrowhead)  The position of the MBP. 
(c) The figure quantitates the ERK2 activity data corresponding to several  experiments similar to the one described in (b). Cells were either unstimulated 
(control) or treated with 100 ng/ml PDBu, 10 t,g/m1 TCR agunist UCHT1, or 0.5/*g/ml ionomycin. Data are expressed as fold induction in MBP 
phosphorylation  as quanfitated by 3  scanning of dried SDS-PAGE gels and are an average (mean  _+  SD) of the results obtained in five experiments 
C. (d) Time course of ERK2-tag stimulation. The experiment was performed  as described above, but the stimulation was for the indicated times. 
Data  are expressed as cpm of 32p incorporated  into MBP as assessed by Ambis 3  scanning. 
of the MBP kinase  assays of ERK2 isolated  from the two 
populations.  Since the level of ERK2-tag protein was similar 
in both populations (Fig. 3 a,/eft), the activity data are directly 
comparable.  The data show a marked increase in the basal- 
specific ERK2-tag kinase activity isolated from v-Ha-ms trans- 
fected cells compared to control cells. (Fig. 3 b, lane C, right 
versus lane C, left). A further increase in ERK2 kinase ac- 
tivity  was  induced  in  the  v-Ha-ras expressing  cells by 
stimulating  the calls with UCHT1 or PDBu. The data in 
Fig. 3 c quantitate  the results of several experiments. All MBP 
kinase activity was normalized  to the level of  ERK2-tag pro- 
teins assessed by 9E10 Western blot analyses. The data show 
than the expression of v-Ha-ras induced an approximate  10- 
fold increase in ERK2 kinase activity in T cells. This is some- 
what lower than the level of ERK2 kinase activity stimu- 
lated by PDBu or UCHT1. However, a direct  comparison 
of the relative effects of v-Ha-ras, PDBu and UCHT1 has 
to allow for the fact that in the ras experiments  ERK2 kinase 
activity is assessed 24 h after v-Ha-ms transfection  and thus 
the ERK2 kinase data from the v-Ha-ms transfected cells reflect 
a prolonged ERK2 kinase  activation  rather than the acute 
activation  seen 5-10 rain after cell stimulation via the TCR 
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Figure  4.  Effect  of a substained stimulation ofJurkat ceUs  with PDBu 
on ERK2-tag. Jurkat cells were cotransfected  with either 30 #g of the 
pEF-ERK2-tag vector and 40 #g of the pEF empty vector (.),  or 10 
#g of the pEF-ERK2-tag vector and 40 #g of the pEFras vector (~). In 
parallel, Jurkat cells were transfected with 30 #g of the pEF-ERK2-tag, 
and after 20 h of transfection, then stimulated for 4 h with  100 ng/ml 
PDBu (Q). All the cultures were harvested after 24 of the transfection, 
and subsequently were either unstimulated (control) or stimulated for 10 
min with 100 ng/ml of PDBu. MBP kinase assays on the 9E10 IPs from 
the lysates were set up and data show MBP kinase activity on the IPs. 
All kinase data was normalized to the level of ERK2-tag expressed in the 
different populations. This was assessed  by Western blot analysis with the 
9E10 antibody. 
Figure  3.  p21~ activates ERK2-tag in Jurkat cells. (a) Jurkat cells were 
cotransfected with either 40 #g of pEFempty vector and 30 #g of pEF- 
ERK2-tag (lane  3), or 40 #g of  the pEFras vector  and 10 #g of  pEF-ERK2- 
tag (lane 2). The figure shows the Western blots corresponding to the 
lysates obtained after 24 h of transfection and developed with 9E10 anti- 
body to visualize ERK2-tag (left) and reprobed with the pan-ras antibody 
(right). Arrowheads  indicate the position corresponding to ERK2tag (.,9) 
and p21~ ( ,~ ). (b) Jurkat cells cotransfected as indicated above  were ei- 
ther unstimulated (C) or stimulated for 10 rain with PDBu (P) or TCR 
agonist (T). 9E10 IPs were carried out in the lysates and ERK2-tag ac- 
tivity was assessed using the MBP kinase assay. The tracks labeled with 
EFe correspond to cells cotransfected  with the pEF empty vector. Tracks 
labeled with EFras are from cells cotransfected with the pEFras vector. 
The results of a representative experiment are shown. (c) The histogram 
or PKC. The data in Fig. 4 show that when the level of  ERK2- 
tag kinase activity is assessed in cells expressing p21 v-Ha-ras 
or stimulated with PDBu for 4  h,  then the level of ERK2 
kinase  activity is comparable and of similar  magnitude. 
A  second explanation for the apparent failure of v-Ha-ras 
to maximally activate ERK2 kinase could be that  the level 
of v-Ha-ras expression was suboptimal.  The data in Fig.  5 
address this point and show the regulation of ERK2 kinase 
activity in cells that express v-Ha-ras at a level of either 2- or 
20-fold excess of endogenous p21  r'~ (Fig. 5 a). A  10-fold in- 
crease in ERK2 kinase  activity occurred in populations  of 
cells expressing 10-fold different levels ofv-Ha-ras. Moreover, 
PKC triggering  could induce  an  additional  stimulation  of 
ERK2 kinase activity in cells dearly expressing optimal levels 
of v-Ha-ras  (Fig.  5  b). 
Detailed dose-response curves are difficult to do in these 
transient transfection experiments because reducing the con- 
centration of ras DNA can reduce the transfection efficiency. 
This makes it possible that subpopulations of cells could ex- 
press the ERK2 reporter construct but not the v-Ha-ras. This 
is impossible to control completely in transient  cotransfec- 
tion studies.  However, in the experiments  in Figs.  3  and 4 
the ratio of v-Ha-ras  to ERK2-tag DNA was at least 4:1 to 
minimize  this  possibility. 
Expression of  p21 NIT ras Prevents Activation of  ERK2.  To 
determine whether p21  ~  function is essential for TCK regu- 
lation of  ERK2, the consequence of the expression of  a dora- 
quantitates the ERK-2 activation data obtained in four experiments per- 
formed as indicated above. Results are expressed as fold induction in MBP 
phosphorylation quantitated as indicated in Fig. 2 c. 
1203  Izquierdo  et al. Figure S.  A low level of constitutively active ras activates ERK2-tag 
in  Jurkat cells. (a) Western blot developed with pan-ras antibody  of  lysates 
from Jurkat cells that were cotransfected with 10/~g of the pEF-ERK2- 
tag vector and either 40 #g (A, lane 2) or 20/~g (/3, lane 5) of the pEF-ras 
vector. As a control, cells were cotransfected with 30 t~g of ERK-tag con- 
struct and either 40/~g (lane 3) or 20/~g (lane 6) of the EF empty vector. 
Lysates from untransfected (lanes I and 4) are included as a reference for 
the levels of endogenous ras for each ~periment. (b) Jurkat cells cotrans- 
fected as indicated above were either unstimulated (control)  or stimulated 
for 10 min with 100 ng/ml PDBu. MBP kinase assays in the 9E10 IPs 
from cells cotransfected with either  the pEF empty (I)  or the pEFras 
vector ([]) were carried out, and the figure shows the quantitation of the 
normalized ERK2-tag activity. The data included in A correspond to the 
lysates from A in the Western blot (higher level of transfected ms) whereas 
the data in B corresponds to the lysates with lower levels  of transfected ms. 
inant inhibitory p21  ras mutant p21 N17 ras on the activation 
of ERK2-tag was assessed. In N17 ras the substitution of serine 
with  asparagine  at codon 17 generates a mutant  that  com- 
petes  with  endogenous  p21TM for  guanine  nucleotide  ex- 
change proteins and thus prevents accumulation of endoge- 
nous p21  ~'s into  the active GTP-bound  state (21).  Previous 
studies (4,  5) have established the specificity of this mutant 
as an inhibitor  of the ras  pathway in T  cells.  Experiments 
examining the consequences of N17 ras expression for ERK2 
regulation in Jurkat cells revealed a dose-dependent hierarchy 
of the  sensitivity of ERK2 activation  to the effects of the 
inhibitory ras mutant.  To monitor the expression of N17 ras, 
Western  blot analysis  using  the  anti-pan  ras  antibody was 
carried out. The ras antibody does not distinguish  the N17 
mutant  from endogenous ras but the relative ratio of N17 
protein to endogenous ras can be inferred from the increase 
in the total levels of ras in the N17 ras transfected cells.  In 
cells  expressing a two- to fourfold excess of N17  ras  com- 
pared to endogenous ras  (Fig.  6 a,  panel A)  the ability of 
ERK2 to be activated in response to PDBu was unchanged 
(Fig. 6 b). However, the responsiveness of the ERK2 kinase 
pathway to regulation via the TCR was strongly inhibited 
(Fig. 6 b). The MBP kinase activity present in the ERK2-tag 
immunoprecipitates  was normalized  to the level of ERK2- 
tag protein  as determined  by Western  blot  analysis  of cell 
lysates with the 9E10 antibody. Quantitation  of the data in 
Fig.  6  b by Ambis scanning,  shows that  the ERK2 kinase 
activity isolated from the TCR stimulated N17 ras transfected 
cells was 70-80%  reduced compared to that found in TCR 
activated control cells. When N17 ras was expressed at levels 
equivalent to or lower than  endogenous ras,  no differences 
in either TCR or PKC activation of ERK2 were observed 
(data not shown). In Jurkat cells expressing higher levels of 
N17 ras, a 10-20-fold excess of N17 ras compared to endoge- 
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tion of ERK2-tag. (a) Western blot developed  with a pan ras mAb of 1y- 
sates from Jurkat cells that were cotransfected with 40/~g of the pEF- 
ERK2-tag vector and either 50/~g (B, hne 4) or 40/~g (A, lane I) of 
the RSVN17 vector. As a control, cells were cotransfected with 30/zg 
of the pEF-ERK2-tag vector and either 50/zg (B, lane 5) or 40/zg (A, 
lane 2) of the RSV empty vector. Lysates  from untransfected cells (lanes 
3 and 6) are included as a reference  for the levels of endogenous ras in 
each experiment. (b) Jurkat ceLls  cotransfected  as indicated in A were ei- 
ther unstimuhted (control)  or stimulated  for 10 rain with 100 ng/ml PDBu 
(P) or 10/~g/ml TCR agonist (7). MBP kinase assays were performed 
on the 9E10  IPs from cells  cotransfected  with either the RSV empty (RS/~) 
or the RSVN17 construct (RSVN 17), and the autoradiography of the 
dried gel is shown. (c) Cells were cotransfected  as indicated in B and MBP 
kinase assays performed as indicated in above. In this case, the data are 
expressed as fold induction in MBP phosphorylation as quantitated by fl 
scanning of the dried gel, and are average (mean _+  SD) of the results 
obtained in four experiments. 
nous ras (Fig. 6 a, panel B) there was a similar 80% inhibi- 
tion of the TCR response and a comparable suppression of 
PDBu  stimulation  of ERK2  (Fig.  6  c). 
Discussion 
Stimulation of the TCR activates p21 ras and initiates a ras 
controlled signaling cascade that is essential for T  cell activa- 
tion (2-5,  24).  The effector pathway downstream  of p21 r's 
has not previously been explored in T  cells, whereas in other 
cell lineages, ras proteins have been shown to couple receptor 
tyrosine kinases to the ERK encoded family of MAP kinases 
(8-10).  In the present study, an experimental system using 
transient transfection protocols was developed to explore the 
role of p21  ra' in the regulation  of the MAP  kinase ERK2. 
The kinase  activity of a  tagged  transfected ERK2  was  as- 
sessed in immunoprecipitates using MBP as a substrate. TCR 
triggering induced a rapid increase in ERK2 activity, peaking 
after 10 min with a  10-15-fold elevation of ERK2 activity. 
PKC stimulation also rapidly activated ERK2, peaking with 
a  15-20-fold elevation of kinase activity.  Increases in cyto- 
solic calcium regulate vital signaling pathways in T  cells (25). 
However,  in  T  cells  treated  with  the  calcium  ionophore 
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ionomycin,  no  EILK2  activation  occurred  indicating  that 
calcium-sensitive  signals  do  not  regulate ERK2  kinase. 
One immediate consequence of TCR. and PKC stimula- 
tion of T  cells is the regulation of the p21  r~ guanine nucleo- 
tide binding cycle, resulting  in increased levels of ras-GTP 
complexes (2). Mutationally activated p21 v-Ha-ras exists pre- 
dominantly in the GTP-bound form in vivo (26).  The ac- 
tivity of ERK2  isolated from Jurkat  cells transfected with 
v-Ha-ras was elevated 10-fold compared to ERK2 isolated from 
control nonstimulated  cells.  The maximum ERK2 activity 
found in v-Ha-ras transfected Jurkat was a little lower than 
the peak of TCK response and 50% of the peak corresponding 
to the PKC response. However, the peak of TCR and PKC 
responses was maintained only transiently and a more appro- 
priate gauge of the relative ability of v-Ha-ras or TCR and 
PKC activators to simulate ERK2 is achieved by looking at 
ERK2 in cells activated over a prolonged period. These data 
(Fig. 4) show that the ERK2 activity present in Jurkat cells 
activated via PKC over a period of several hours was  com- 
parable to the ERK2 activity isolated from the v-Ha-ras ex- 
pressing cells. This implies that the relative potency of v-Ha-ras 
with regard to MAP kinase regulation is similar to PKC and 
TCR  activators. The pathway that couples the TCR to ERK2 is not ap- 
parent from these initial experiments with the activated ras. 
We have shown previously that the TCR is able to stimulate 
endogenous  p21 "s  and  PKC  in  apparently  independent 
pathways (3). There is, accordingly, the potential for the TCR 
to use either a PKC pathway to activate ERK2 or a ras con- 
trolled pathway. One strategy to explore the contribution 
of ras to TCR/ERK2  coupling is to examine the effect of 
a dominant inhibitory ras mutant N17 ras on TCR activa- 
tion of ERK2. 
GTP levels on ras are controlled by a balance of the activi- 
ties of guanine nucleotide exchange proteins and ras GTPase 
activating proteins (27). The dominant inhibitory ras mutant 
N17 competes with endogenous ras for guanine nucleotide 
exchange proteins and this competitive interaction prevents 
exchange of GTP onto endogenous ras thereby preventing 
ras activation (21). The data presented here show that removal 
of endogenous p21TM function by expression of N17 ras pre- 
vents TCR-mediated activation of ERK2. This result indi- 
cates that the TCR is coupled to ERK2 via a p21 ~'* depen- 
dent pathway. Previous studies have suggested that a tyrosine 
kinase p56  ~k may have a role in TCR regulation of the MAP 
kinases (13). We have shown that the TCR activates the ras 
proteins  via  a  protein  tyrosine  kinase  inhibitor  sensitive 
pathway (3).  Thus tyrosine kinases such as p56  Ick may have 
an indirect regulatory effect on the MAP kinase via involve- 
ment in the mechanisms that couple the TCR to p21 ~  (13). 
Recent studies (11) have implicated PKC as a MAP kinase 
regulator in T cells. However, PKC does not mediate TCR 
activation of ras  (3) and thus is unlikely to have a role in 
the ras pathway that couples the TCR to ERK2. The posi- 
tioning of ras in the PKC signaling pathways is dependent 
on cell lineage (28, 29). For example, in fibroblasts and COS-1 
cells, PKC-induced ERK2 activation is independent of p21 r~ 
and PKC contributes to a parallel pathway for ERKs regula- 
tion (10, 19). In T cells in which the stimulation of ERK2 
by p21 r'~ is maximal (Fig.  5), a further induction of ERK2 
kinase activity could be achieved by PKC or TCR triggering 
(Fig. 3). Thus PKC and the TCR appear to contribute a signal 
additive with the p21r--mediated signal for ERK2  activa- 
tion.  Our previous studies have indicated that p21 r'~ may 
have a role downstream of PKC in T cells. This hypothesis 
was suggested by the stimulatory effect of PKC on the p21 '~ 
guanine nucleotide binding cycle (2). In Jurkat cells, the ex- 
pression  of the inhibitory ras  mutant,  N17  ras,  not  only 
prevented TCR activation of ERK2 but could prevent the 
PKC-induced ERK2 response. However, there was a marked 
difference in the susceptibility of the TCR and PKC/ERK2 
response for N17 inhibition (Fig.  6). Since PKC can induce 
a more potent stimulation of p21 ~  than the TCR (Fig.  1), 
it is not unexpected that the PKC response is more resistant 
to inhibition. Nonetheless, the difference in sensitivity to N17 
ras could reflect that in T  cells, as in fibroblasts,  PKC acti- 
vates  ERK2 via a ras-independent pathway. 
In fibroblasts, the N17 ras mutant inhibits ras function when 
expressed at a level at least 20-fold lower than wild-type ras 
(21).  However, from the present data it appears  that in T 
cells, at least a two- to fourfold excess of N17 ras compared 
to endogenous ras is required to block TCR activation of 
ERK2. This discrepancy probably reflects the fundamental 
differences in ras guanine nucleotide mechanisms that appar- 
ently exist between T cells and other cell types. In fibroblasts, 
for example guanine nucleotide exchange on ras is regulated 
by triggering receptors such as the epidermal growth factor 
receptor (EGFR)  (30).  The ras exchange protein in fibro- 
blasts is the mammalian homologue of the Drosophila SOS 
gene (31).  EGF recruits SOS to the cell membrane by in- 
ducing association of SOS with the EGF receptor cytoplasmic 
domain. This EGFR/SOS  association is mediated via the 
adaptor protein Grb2/Sem5 (32). In T cells there is no com- 
parable tight coupling of receptor stimulation to the regula- 
tion of ras guanine nucleotide exchange. In T cells, guanine 
nucleotide exchange on p21 r~ is constitutively high (2) and 
the increases in ras-GTP levels that occur in TCR- or PKC- 
activated T cells can be attributed to inactivation of ras GAP 
proteins (2, 33).  The molecular basis for the constitutively 
high nucleotide exchange on ras in T  cells is not dear.  T 
cells may use a ras exchange protein distinct to the SOS ex- 
change protein with different characteristics for regulation. 
Alternatively, levels of exchange proteins and hence basal ex- 
change activity may be higher in T cells than fibroblasts. Differ- 
ences in the level of ras exchange proteins or their regulation 
would explain differences in the sensitivity of endogenous 
ras function to the N17 ras mutant. 
Ras does not directly stimulate MAP kinases but regulates 
a signaling cascade which has been well characterized in some 
cell lineages (34).  Directly upstream of MAP kinases is an 
activator kinase, MAP kinase kinase (MAP KK).  The link 
between p21 r~s and the MAP KK is provided by at least one 
other kinase, MAP kinase kinase kinase (MAPKKK). Two 
candidates for the MAPKKK have been described, the pro- 
tooncogene Raf-1 (19) and a kinase termed MEK1 (35). Raf-1 
can be regulated via at least two pathways: one mediated by 
p21TM and one controlled by PKC (36, 37).  Raf-1 is activated 
in T  cells by both TCR and PKC triggering (38,  39)  and 
may provide the link between ras or PKC and ERK2. Ac- 
cordingly, the positioning of p21 '~ in the mechanisms that 
couple the TCR to ERK2 provides a framework for posi- 
tioning other potentially important signaling molecules in 
the TCR signal transduction pathways. Further studies are 
required to establish both the nature and the contribution 
of the different components of the ERK activation cascade 
in T cells. Since it has been shown that ERKs can phosphory- 
late and regulate the activity of transcriptional factors such 
as c-jun,  c-myc,  and Elk1  (40-42),  the ras-regulated ERK- 
mediated cascade could act to couple the TCR to the regula- 
tion of gene transcription in the nucleus. 
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